all report title image

TYPHOID FEVER VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Typhoid Fever Vaccines Market, By Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, Others), By Route of Administration (Oral, Parenteral), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 19 Feb, 2026
  • Code: CMI2552
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Vaccine Type
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Novel Product Launch/Approval
    • PEST Analysis
    • Awareness Strategy
    • Reimbursement Scenario
    • Typhoid Fever Vaccines Shortage
    • Clinical Trial Analysis
    • Countries with High Number of Incidents of Snake Bites
    • Market Entry Challenges
  4. Global Typhoid Fever Vaccines Market, By Vaccine Type, 2026 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Live Attenuated Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Capsular Polysaccharide Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Conjugate Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
  5. Global Typhoid Fever Vaccines Market, By Route of Administration, 2026 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Parental
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
  6. Global Typhoid Fever Vaccines Market, By Region, 2026 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2026–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
      • GlaxoSmithKline Plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sanofi SA
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bharat Biotech
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bio-Med Pvt. Ltd.
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • PT Bio Farma
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • PaxVax, Inc.
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Shanghai Institute of Biological Products Co., Ltd.
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Prokarium
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section

    • References
    • Research Methodology
    • About Us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.